Navigation Links
Mapping the genetic locus for triglycerides

Researchers have mapped out a region on human chromosome 1 that contributes to genetically elevated blood triglyceride levels, a major risk factor for heart disease.

Triglycerides (TG), the main form of dietary fat, continuously circulate in the blood, but if their concentration elevates the risk of atherosclerosis and subsequently heart disease increases. Circulating TG levels depend on many factors including diet, exercise, and smoking, but around 40% of the variation in the population is due to genetics.

To locate the genes contributing to increased TG levels, Qing Wang and colleagues scanned 714 Caucasians from 388 families with premature heart disease. They identified a novel region on chromosome 1, 1p31-32.

While this genetic locus does contain 375 known genes, the researchers highlighted three genes that are especially promising candidates: angiopoietin-like 3, which inhibits enzymes that break down fats; the receptor for the appetite hormone leptin; and sterol carrier protein 2, which helps convert cholesterol into bile acids.

The researchers also note that another recent study identified a single nucleotide polymorphism associated with elevated TG levels in the exact same region, solidifying this part of chromosome 1 as the TG region.


Contact: Nick Zagorski
American Society for Biochemistry and Molecular Biology

Page: 1

Related biology news :

1. Prediction of RNA pseudoknots using heuristic modeling with mapping and sequential folding
2. Genetic sequencing of protein from T. rex bone confirms dinosaurs link to birds
3. American College of Medical Genetics makes genetic testing recommendations in new policy statement
4. Scientists clarify a mechanism of epigenetic inheritance
5. Genetic variant mimics effect of heart failure medications
6. Researchers discover critical detail of cellular defense against genetic mistakes
7. Concentrating on different aspects of pain leads to breakthrough in migraine genetics
8. Genetic Engineering & Biotechnology News reports on growing use of cell-based assays
9. Largest ever study of genetics of common disease just got bigger
10. A genetic cause for iron deficiency
11. Geneticist Francis Collins named first recipient of Inamori Ethics Prize at Case Western Reserve
Post Your Comments:
(Date:11/19/2015)... NEW YORK , Nov. 19, 2015  Although ... the market is dominated by a few companies, according ... Qiagen. These companies own 51% of the market share of ... report, The World Market for Molecular Diagnostic ... "The market is still controlled by one ...
(Date:11/17/2015)... -- Paris from 17 th ... Paris from 17 th until 19 th ... has invented the first combined scanner in the world which ... surface. Until now two different scanners were required: one for ... on the same surface. This innovation is an ideal ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, ... in the development and sale of broadly enabling, pressure ... life sciences industry, today announced it has received gross ... $5 million Private Placement (the "Offering"), increasing the total ...  One or more additional closings are expected in the ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... Kingdom , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc ... company, announced today that it has closed the sale ... business to Guerbet (GBT- NYSE Euronext) in a transaction ... encompassed four manufacturing facilities and a total of approximately ... in the St. Louis area. ...
(Date:11/26/2015)... , November 26, 2015 ... --> Accutest Research Laboratories, a ... Research Organization (CRO), has formed a ... Center - Temple Health for joint ... ,     (Photo: ) , ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 ... a biotechnology company developing bioengineered organ implants for life-threatening ... will present at the LD Micro "Main Event" investor ... PT. The presentation will be webcast live and posted ... also be available at the conference for one-on-one meetings ...
Breaking Biology Technology: